Our Why

“We are leveraging our cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases.”

Søren Tulstrup, President and CEO

 

Latest news

Stockholm -1.60 HNSA   257.60 SEK
 
22Jan

SEB Annual Pharma & Biotech Seminar

Stockholm
23Jan

Road Show RBC

London
06Feb

Interim Report Oct-Dec 2019

18Feb

Road Show Kempen

Paris
19Feb

Road Show Kempen

Tel Aviv
02Mar

Cowen Annual Health Care Conference

Boston
04Mar

Carnegie Nordic Healthcare Seminar

Stockholm, Sweden
02Apr

Annual Report 2019

21Apr

Kempen Life Sciences Conference

Amsterdam
28Apr

Interim Report Jan-Mar 2020

19May

RBC Global Healthcare Conference

NYC
26May

ABG Life Science Summit

Stockholm
27May

Ökonomisk Ugebrev Life Science Conference

Copenhagen

Introduction to Hansa

Søren Tulstrup, President & CEO


Hansa in brief
left-photo-mask

Join Hansa

From our headquarters in Lund, Sweden, we reach around the world. Our dedicated team includes experienced and courageous specialists driven by our purpose to develop lifesaving and life altering therapies for patients living with rare immunological diseases.

Since our founding in 2007, we have worked in cross functional and agile teams. We are gender-balanced, comprise 14 different nationalities and see diversity as an enabler for reaching our corporate objectives. The recruitment of highly motivated, experienced and talented team players supports our development towards a fully integrated global biopharmaceutical company.

Careers